Prevention of Cholera disease research hub

A Phase I, Open-label, Randomized, Active-Controlled, to Evaluate the Safety and Immunogenicity of the DuoChol Oral Cholera Vaccine in 18 to 45 years old Healthy Participants in Sweden.

This study is testing a new oral cholera vaccine called DuoChol in healthy Swedish adults aged 18-45. It's a very early stage trial, looking at how safe the vaccine is and how well it helps the body fight off cholera.